Increased Local Failure for Patients with Intermediate-Risk Rhabdomyosarcoma on ARST0531: A Report from the Children’s Oncology Group

BACKGROUND: To evaluate local control for patients with intermediate-risk rhabdomyosarcoma (RMS) treated on Children’s Oncology Group (COG) protocol ARST0531. METHODS: We analyzed 424 patients with intermediate-risk RMS. Patients were randomized to chemotherapy with either vincristine, dactinomycin,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer
Hlavní autoři: Casey, Dana L., Chi, Yueh-Yun, Donaldson, Sarah S., Hawkins, Douglas S., Tian, Jing, Arndt, Carola A., Rodeberg, David A., Routh, Jonathan C., Lautz, Timothy B., Gupta, Abha A., Yock, Torunn I., Wolden, Suzanne L.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2019
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6717036/
https://ncbi.nlm.nih.gov/pubmed/31174239
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.32204
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky